Dr. Agarwal's Health Care Ltd. (IN:AGARWALEYE)
:AGARWALEYE
Want to see IN:AGARWALEYE full AI Analyst Report?
AGARWALEYE Stock Chart & Stats
₹500.00
--
Market closed
₹500.00
--
Day’s Range― - ―
52-Week Range₹385.65 - ₹567.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)13.83K
Market Cap
₹148.27B
Enterprise Value₹149.86B
Total Cash (Recent Filing)₹3.97B
Total Debt (Recent Filing)₹9.83B
Price to Earnings (P/E)106.1
Beta0.62
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.66
Shares Outstanding316,983,030
10 Day Avg. Volume7,500
30 Day Avg. Volume13,832
Financial Highlights & Ratios
PEG Ratio1.92
Price to Book (P/B)6.35
Price to Sales (P/S)6.18
P/FCF Ratio188.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5.81
Revenue Forecast (FY)₹25.21B
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue Scale-upSustained multi-year revenue growth and rising net income indicate the business is expanding its clinic/hospital footprint and patient volumes, creating durable scale advantages. Larger revenue base supports fixed-cost absorption, investment in capabilities, and long-term competitive positioning across ophthalmic services.
Material De-risking Of LeverageA meaningful reduction in leverage over several years reduces refinancing and liquidity risk and increases strategic optionality. With lower relative debt the company has greater capacity to invest in network expansion, capex or acquisitions without materially increasing financial strain, improving long-term resilience.
Stronger Operating Cash GenerationImproved operating cash flow that modestly exceeds net income in 2026 reflects better cash conversion from core operations. Consistent positive OCF enhances ability to fund working capital, maintain clinics, and support reinvestment without relying solely on external financing, bolstering long-term self-funded growth.
Bears Say
Margin Volatility & Gross CompressionSignificant swings in gross and net margins reduce predictability of operating profitability and weaken durable pricing power. Persistent or recurring margin compression can erode returns on incremental revenue and complicate capital allocation, making sustainable margin recovery key to long-term value creation.
Weak And Inconsistent Free Cash FlowLow and volatile free cash flow relative to profits limits genuine cash available for dividends, deleveraging or M&A. Even with higher operating cash, thin FCF conversion reduces financial flexibility and raises sensitivity to working-capital swings or higher capex, constraining long-term strategic moves.
Sizable Absolute Debt And Modest ReturnsAlthough leverage ratios improved, material absolute debt levels combined with modest ROE indicate returns are not yet high relative to capital employed. This can limit reinvestment returns and leaves the company exposed if growth slows, making uplift in operating returns critical for durable shareholder value.
Dr. Agarwal's Health Care Ltd. News
AGARWALEYE FAQ
What was Dr. Agarwal's Health Care Ltd.’s price range in the past 12 months?
Dr. Agarwal's Health Care Ltd. lowest stock price was ₹385.65 and its highest was ₹567.80 in the past 12 months.
What is Dr. Agarwal's Health Care Ltd.’s market cap?
Dr. Agarwal's Health Care Ltd.’s market cap is ₹148.27B.
When is Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date?
Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date is Aug 18, 2026 which is in 57 days.
How were Dr. Agarwal's Health Care Ltd.’s earnings last quarter?
Dr. Agarwal's Health Care Ltd. released its earnings results on May 21, 2026. The company reported ₹1.2 earnings per share for the quarter, beating the consensus estimate of ₹1.067 by ₹0.133.
Is Dr. Agarwal's Health Care Ltd. overvalued?
According to Wall Street analysts Dr. Agarwal's Health Care Ltd.’s price is currently Overvalued.
Does Dr. Agarwal's Health Care Ltd. pay dividends?
Dr. Agarwal's Health Care Ltd. does not currently pay dividends.
What is Dr. Agarwal's Health Care Ltd.’s EPS estimate?
Dr. Agarwal's Health Care Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dr. Agarwal's Health Care Ltd. have?
Dr. Agarwal's Health Care Ltd. has 316,983,030 shares outstanding.
What happened to Dr. Agarwal's Health Care Ltd.’s price movement after its last earnings report?
Dr. Agarwal's Health Care Ltd. reported an EPS of ₹1.2 in its last earnings report, beating expectations of ₹1.067. Following the earnings report the stock price went up 4.228%.
Which hedge fund is a major shareholder of Dr. Agarwal's Health Care Ltd.?
Currently, no hedge funds are holding shares in IN:AGARWALEYE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Dr. Agarwal's Health Care Ltd.
Dr. Agarwal's Health Care Limited manages a chain of eye hospitals both within India and abroad. The company delivers a comprehensive range of ophthalmic services, including advanced surgical solutions for cataracts like small incision, phacoemulsification, robotic, and glued intraocular lens procedures. It also offers refractive surgeries designed to correct visual errors, thereby lessening or removing the necessity for glasses and contact lenses. Additional surgical specialties include treatments for retinal conditions, corneal transplantation, pinhole pupilloplasty, oculoplasty, and operations for glaucoma and pterygium. Beyond surgical interventions, the company provides professional medical consultations, in-depth diagnostic services for various eye disorders, and non-surgical therapies such as retinal laser treatment and dry eye management. Furthermore, Dr. Agarwal's Health Care Limited sells optical goods, including spectacles, lenses, contact lenses, and frames, as well as a variety of pharmaceutical products for eye care. The company was founded in 2010 and is based in Chennai, India.
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Jupiter Life Line Hospitals Ltd.
―
Marksans Pharma Limited
―
Metropolis Healthcare Ltd.
―
Rainbow Childrens Medicare Limited
―